Company Filing History:
2 out of 71 
1 out of 832,843 Years Active: 2019-2022
Title: Kristen Pierce: Innovator in Cancer Treatment
Introduction
Kristen Pierce is a prominent inventor based in Burlingame, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new therapeutic agents. With a total of 3 patents, her work focuses on advancing medical science and improving patient outcomes.
Latest Patents
Kristen's latest patents include groundbreaking inventions such as FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatment. This patent outlines the uses of fibroblast growth factor receptor 2 (FGFR2) inhibitors, which can be utilized in conjunction with immune stimulating agents like PD-1 or PD-L1 inhibitors. The invention details various embodiments, including FGFR2 antibodies and fusion molecules that enhance the efficacy of cancer therapies. Another notable patent is for afucosylated anti-FGFR2IIIb antibodies, which bind to FGFR2IIIb and are designed to treat cancer effectively. This patent emphasizes the importance of afucosylation in enhancing the therapeutic potential of these antibodies.
Career Highlights
Throughout her career, Kristen has worked with notable companies, including Five Prime Therapeutics, Inc. Her experience in the biotechnology sector has allowed her to develop innovative solutions that address critical challenges in cancer treatment.
Collaborations
Kristen has collaborated with esteemed colleagues such as Thomas Harding and Namrata Patil. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Kristen Pierce is a trailblazer in the field of cancer treatment, with a focus on developing innovative therapies that leverage the power of FGFR2 inhibitors. Her contributions to medical science are paving the way for new treatment options that can significantly improve patient care.